|
MedChemExpress
p38 map kinase inhibitor sb202196 ![]() P38 Map Kinase Inhibitor Sb202196, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p+p38+mapk/Phospho-p38+alpha%2FMAPK14+(Thr180%2BTyr182)+Antibody/pmc10252550-58-89-96 Average 97 stars, based on 1 article reviews
p38 map kinase inhibitor sb202196 - by Bioz Stars,
2026-11
97/100 stars
|
Buy from Supplier |
|
Bioss
p38 mapk (thr180) polyclonal antibody ![]() P38 Mapk (Thr180) Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p+p38+mapk/P38+MAPK+(Thr180)+Polyclonal+Antibody/custom%40bs-5476r%4029085476 Average 94 stars, based on 1 article reviews
p38 mapk (thr180) polyclonal antibody - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Becton Dickinson
mouse anti-p38 mapk monoclonal (612280) ![]() Mouse Anti P38 Mapk Monoclonal (612280), supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p+p38+mapk/mouse+anti+p+p38+mapk+monoclonal++612168+/pmc05114426-632-5-26 Average 90 stars, based on 1 article reviews
mouse anti-p38 mapk monoclonal (612280) - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Servicebio Inc
anti-p-p38 antibody (catalog number gb113380) ![]() Anti P P38 Antibody (Catalog Number Gb113380), supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p+p38+mapk/rabbit+anti+p+p38+mapk/pmc11019850-208-7-42 Average 90 stars, based on 1 article reviews
anti-p-p38 antibody (catalog number gb113380) - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Abbiotec Inc
phospho (p)-p38 mapk ![]() Phospho (P) P38 Mapk, supplied by Abbiotec Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p+p38+mapk/p+p38+mapk+antibody/pmc06929072-9-0-6 Average 90 stars, based on 1 article reviews
phospho (p)-p38 mapk - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Keygen Biotech
p-p38 mapk antibody ![]() P P38 Mapk Antibody, supplied by Keygen Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p+p38+mapk/p+p38+mapk+antibody/pmc05812251-50-91-102 Average 90 stars, based on 1 article reviews
p-p38 mapk antibody - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Promega
anti-p-p38 mapk antibody (tb262) ![]() Anti P P38 Mapk Antibody (Tb262), supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p+p38+mapk/anti+p+p38+mapk+antibody++tb262+/pmc04759193-132-101-107 Average 90 stars, based on 1 article reviews
anti-p-p38 mapk antibody (tb262) - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Abace Biotechnology Co Ltd
mouse monoclonal anti-p-p38 mapk (d-8; 1:1000) antibodies ![]() Mouse Monoclonal Anti P P38 Mapk (D 8; 1:1000) Antibodies, supplied by Abace Biotechnology Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p+p38+mapk/mouse+monoclonal+anti+p+p38+mapk++d+8++1+1000++antibodies/pmc04503025-92-8-15 Average 90 stars, based on 1 article reviews
mouse monoclonal anti-p-p38 mapk (d-8; 1:1000) antibodies - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Bioss
p38 mapk (thr180 + tyr182) antibody ![]() P38 Mapk (Thr180 + Tyr182) Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p+p38+mapk/P38+MAPK+(Thr180+%2B+Tyr182)+Antibody/custom%40bs-0636r%4032515468 Average 94 stars, based on 1 article reviews
p38 mapk (thr180 + tyr182) antibody - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Bio-Techne corporation
p38 alpha [p thr180, p tyr182] antibody ![]() P38 Alpha [P Thr180, P Tyr182] Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p+p38+mapk/p38+alpha+%5Bp+Thr180%2C+p+Tyr182%5D+Antibody/bio-techne+corporation___nb500-138 Average 94 stars, based on 1 article reviews
p38 alpha [p thr180, p tyr182] antibody - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Bioss
p38 mapk (tyr323) polyclonal antibody ![]() P38 Mapk (Tyr323) Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p+p38+mapk/p38+MAPK+(Tyr323)+Polyclonal+Antibody/bioss___bs-5477r Average 91 stars, based on 1 article reviews
p38 mapk (tyr323) polyclonal antibody - by Bioz Stars,
2026-11
91/100 stars
|
Buy from Supplier |
|
Cell Signaling Technology Inc
phospho-p38 mapk (thr180/tyr182) antibody ![]() Phospho P38 Mapk (Thr180/Tyr182) Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p+p38+mapk/Phospho-p38+MAPK+(Thr180%2FTyr182)+Antibody/cell+signaling+technology+inc___9211 Average 97 stars, based on 1 article reviews
phospho-p38 mapk (thr180/tyr182) antibody - by Bioz Stars,
2026-11
97/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Cells
Article Title: Intracellular Angiotensin II Stimulation of Sodium Transporter Expression in Proximal Tubule Cells via AT 1 (AT 1a ) Receptor-Mediated, MAP Kinases ERK1/2- and NF-кB-Dependent Signaling Pathways
doi: 10.3390/cells12111492
Figure Lengend Snippet: The roles of the MAP kinase and NF-κB signaling pathways in mediating ECFP/Ang II-induced NHE3 expression in wild-type and Agtr1a -/- mPCT cells. Panel ( A ) shows that in wild-type mPCT cells, ECFP/Ang II stimulated NHE3 expression significantly, and the response was attenuated by the MEK1/MEK2 kinase inhibitor U0126 and the NF-κB activation inhibitor Ro 106–9920, respectively. However, the MEK inhibitor PD 980659 and the p38 MAP kinase inhibitor SB202196 failed to attenuate the effect of ECFP/Ang II on NHE3 expression. Panel ( B ) shows that in Agtr1a -/- mPCT cells, ECFP/Ang II failed to stimulate NHE3 expression, and the inhibitors of the MAP kinases and NF-κB signaling pathways had no significant effects on NHE3 expression. ** p < 0.01 vs. control WT mPCT cells. ++ p < 0.01 vs. WT mPCT cells transfected with ECFP/Ang II.
Article Snippet: To determine the potential signaling mechanisms involved in Ad- Sglt2-ECFP/Ang II -induced biological responses, WT and Agtr1a -/- mPCT cells expressing Ad- Sglt2-ECFP/Ang II were concurrently treated with the AT 1 receptor antagonist losartan (10 μM; Tocris, Minneapolis, MN, USA), the AT 2 receptor antagonist PD 123319 (10 μM; Tocris, Minneapolis, MN, USA), the MEK1/MEK2 kinase inhibitor U0126 (1 μM; Tocris, Minneapolis, MN, USA), the MEK inhibitor PD 980659 (1 μM; Tocris, Minneapolis, MN, USA), the NF-κB activation inhibitor RO 106–9920 (10 μM; Tocris, Minneapolis, MN, USA), and the
Techniques: Protein-Protein interactions, Expressing, Activation Assay, Control, Transfection
Journal: Cells
Article Title: Intracellular Angiotensin II Stimulation of Sodium Transporter Expression in Proximal Tubule Cells via AT 1 (AT 1a ) Receptor-Mediated, MAP Kinases ERK1/2- and NF-кB-Dependent Signaling Pathways
doi: 10.3390/cells12111492
Figure Lengend Snippet: The roles of AT 1 and AT 2 receptors, the MAP kinases, and NF-κB signaling pathways in mediating ECFP/Ang II-induced Na + /HCO 3 - cotransporter expression in wild-type mPCT cells. Panel ( A ) shows that ECFP/Ang II significantly increased Na + /HCO 3 - expression, and the response was attenuated by losartan but not by PD123319, suggesting a dominant role of AT 1 receptors in mPCT cells. Panel ( B ) shows that the MEK1/MEK2 kinase inhibitor U0126, the NF-κB activation inhibitor Ro 106–9920, and the MEK inhibitor PD 980659 attenuated the effects of ECFP/Ang II on expression, but the p38 MAP kinase inhibitor SB202196 had no effect on Na + /HCO 3 - expression. ** p < 0.01 vs. control WT mPCT cells. ++ p < 0.01 vs. WT mPCT cells transfected with ECFP/Ang II.
Article Snippet: To determine the potential signaling mechanisms involved in Ad- Sglt2-ECFP/Ang II -induced biological responses, WT and Agtr1a -/- mPCT cells expressing Ad- Sglt2-ECFP/Ang II were concurrently treated with the AT 1 receptor antagonist losartan (10 μM; Tocris, Minneapolis, MN, USA), the AT 2 receptor antagonist PD 123319 (10 μM; Tocris, Minneapolis, MN, USA), the MEK1/MEK2 kinase inhibitor U0126 (1 μM; Tocris, Minneapolis, MN, USA), the MEK inhibitor PD 980659 (1 μM; Tocris, Minneapolis, MN, USA), the NF-κB activation inhibitor RO 106–9920 (10 μM; Tocris, Minneapolis, MN, USA), and the
Techniques: Protein-Protein interactions, Expressing, Activation Assay, Control, Transfection
Journal: Cells
Article Title: Intracellular Angiotensin II Stimulation of Sodium Transporter Expression in Proximal Tubule Cells via AT 1 (AT 1a ) Receptor-Mediated, MAP Kinases ERK1/2- and NF-кB-Dependent Signaling Pathways
doi: 10.3390/cells12111492
Figure Lengend Snippet: The roles of AT 1 and AT 2 receptors, the MAP kinases, and NF-κB signaling pathways in mediating ECFP/Ang II-induced NF-κB, p65 expression in wild-type and Agtr1a -/- mPCT cells. Panel ( A ) shows that ECFP/Ang II increased NF-κB, p65 expression in wild-type mPCT cells, and the response was attenuated by both losartan and PD123319, supporting an important role of AT 1 and AT 2 receptors in mediating ECFP/Ang II-induced NF-κB, p65 expression in wild-type mPCT cells. Panel ( B ) shows that ECFP/Ang II alone had no significant effect on NF-κB, p65 expression in Agtr1a -/- mPCT cells, but both losartan and PD123319 potentiated this response. Panel ( C ) shows that in wild-type mPCT cells, the effect of ECFP/Ang II on NF-κB, p65 expression was attenuated by the MEK1/MEK2 kinase inhibitor U0126, the NF-κB activation inhibitor Ro 106–9920, and the MEK inhibitor PD 980659, respectively. However, the p38 MAP kinase inhibitor SB202196 had no effect on ECFP/Ang II-induced NF-κB, p65 expression in wild-type mPCT cells. ** p < 0.01 vs. control WT or Agtr1a -/- mPCT cells. ++ p < 0.01 vs. WT mPCT cells transfected with ECFP/Ang II, or Agtr1a -/- mPCT cells transfected with ECFP/ANG II.
Article Snippet: To determine the potential signaling mechanisms involved in Ad- Sglt2-ECFP/Ang II -induced biological responses, WT and Agtr1a -/- mPCT cells expressing Ad- Sglt2-ECFP/Ang II were concurrently treated with the AT 1 receptor antagonist losartan (10 μM; Tocris, Minneapolis, MN, USA), the AT 2 receptor antagonist PD 123319 (10 μM; Tocris, Minneapolis, MN, USA), the MEK1/MEK2 kinase inhibitor U0126 (1 μM; Tocris, Minneapolis, MN, USA), the MEK inhibitor PD 980659 (1 μM; Tocris, Minneapolis, MN, USA), the NF-κB activation inhibitor RO 106–9920 (10 μM; Tocris, Minneapolis, MN, USA), and the
Techniques: Protein-Protein interactions, Expressing, Activation Assay, Control, Transfection
Journal: Journal of Virology
Article Title: Hyperoside inhibits EHV-8 infection via alleviating oxidative stress and IFN production through activating JNK/Keap1/Nrf2/HO-1 signaling pathways
doi: 10.1128/jvi.00159-24
Figure Lengend Snippet: Hyperoside induced JNK-MAPK activation to stimulate the Nrf2-HO-1 pathway. ( A ) Hyperoside increased JNK phosphorylation. NBL-6 cells were incubated with 80 µM of hyperoside and harvested at the indicated time points (0, 15, 30, 60, and 120 min) to analyze the phosphorylated and total levels of the ERK1/2, JNK, and p38 proteins using Western blot. ( B ) SP600125 decreased HO-1 expression. NBL-6 cells were incubated with a JNK inhibitor (SP600125), ERK1/2 inhibitor (PD98059), and p38 inhibitor (SB203580) for 2 h, and the cells were then collected to test HO-1 expression using qPCR. *** P < 0.001. ( C ) Hyperoside promoted the nuclear translocation of Nrf2. NBL-6 cells were pretreated with 80 µM hyperoside for 2 h and infected with EHV-8 SDLC66 (0.1 MOI) for 1 h. The protein expression of Nrf2 in the cytoplasmic and nuclear fractions was analyzed using Western blot at 24 hpi. Tubulin and Lamin B were used as the controls. Meanwhile, the amount of p-JNK expression in the total cellular protein fraction was also determined using Western blot ( D ). NBL-6 cells were incubated with a mixture of hyperoside (80 µM) and a JNK inhibitor (SP600125) for 2 h, before infection with EHV-8 SDLC66 (0.1 MOI). The cells were collected to test HO-1 and gD expression using qPCR ( E ) and Western blot ( F ) at 24 hpi. GAPDH served as the internal control. ** P < 0.01; *** P < 0.001.
Article Snippet: Additionally, the anti-JNK antibody (catalog number GB114321),
Techniques: Activation Assay, Incubation, Western Blot, Expressing, Translocation Assay, Infection
Journal: International Journal of Molecular Sciences
Article Title: The Regional Specific Alterations in BBB Permeability are Relevant to the Differential Responses of 67-kDa LR Expression in Endothelial Cells and Astrocytes Following Status Epilepticus
doi: 10.3390/ijms20236025
Figure Lengend Snippet: Effects of 67-kDa LR (LR) neutralization on expressions of laminin, VEGF, 67-kDa LR, and SMI-71, and p38 MAPK phosphorylation in the hippocampus and the PC of normal animals. The 67-kDa LR IgG infusion increased expressions of laminin and VEGF, and p38 MAPK phosphorylation in the PC more than the hippocampus without changing 67-kDa LR expression. The 67-kDa LR neutralization also diminished SMI-71 expression in the PC more than the hippocampus. ( A ) Western blot image for expression levels of laminin, VEGF, 67-kDa LR, and p38 MAPK phosphorylation induced by 67-kDa LR neutralization. ( B ) Quantitative values (mean ± S.E.M) of the western blot data concerning expression levels of laminin, VEGF, and 67-kDa LR, and p38 MAPK phosphorylation induced by 67-kDa LR neutralization ( n = 7, respectively). Open circles indicate each value. Horizontal bars indicate the mean value. Significant differences are * ,# p < 0.05 vs. control IgG (unpaired Student’s t -test) and the hippocampus (paired Student’s t -test), respectively.
Article Snippet:
Techniques: Neutralization, Expressing, Western Blot
Journal: International Journal of Molecular Sciences
Article Title: The Regional Specific Alterations in BBB Permeability are Relevant to the Differential Responses of 67-kDa LR Expression in Endothelial Cells and Astrocytes Following Status Epilepticus
doi: 10.3390/ijms20236025
Figure Lengend Snippet: Primary antibodies used in the present study.
Article Snippet:
Techniques: Plasmid Preparation
Journal: Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
Article Title: Silencing Ras-Related C3 Botulinum Toxin Substrate 1 Inhibits Growth and Migration of Hypopharyngeal Squamous Cell Carcinoma via the P38 Mitogen-Activated Protein Kinase Signaling Pathway
doi: 10.12659/MSM.907468
Figure Lengend Snippet: Silencing Rac1 inhibits the activation of P38 MAPK signal in vitro . The levels of MKK3 and p-MKK3 ( A, B ) and P38 and p-P38 ( C, D ) were detected by Western blot analysis. GAPDH served as the internal reference. All experiments were repeated 3 times and the results are presented as mean ±SD. *** P<0.001 compared with the negative control group.
Article Snippet: The membranes were blocked with 5% skim milk or 1% bovine serum albumin, and then incubated with Rac1 antibody, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antibody (1: 1000; Proteintech, Wuhan, China), Cyclin D1 antibody (1: 1000; BOSTER, Wuhan, China), Cyclin E antibody, Cyclin B antibody (1: 500; Bioss, Beijing, China), metal matrix proteinase (MMP)-2 antibody, MMP-9 antibody, B cell lymphoma-2 (Bcl-2) antibody, Bcl-2-associated X protein (Bax) antibody, phosphorylated-MAP kinase (p-MKK3) antibody (1: 500; Sangon Biotech, Shanghai, China), caspase-3 antibody, caspase-9 antibody, poly ADP-ribose polymerase (PARP) antibody (1: 1000; Cell Signaling Technology, Beverly, MA, USA),
Techniques: Activation Assay, In Vitro, Western Blot, Negative Control
Journal: Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
Article Title: Silencing Ras-Related C3 Botulinum Toxin Substrate 1 Inhibits Growth and Migration of Hypopharyngeal Squamous Cell Carcinoma via the P38 Mitogen-Activated Protein Kinase Signaling Pathway
doi: 10.12659/MSM.907468
Figure Lengend Snippet: Rac1 silencing inhibits the activation of P38 MAPK signal in vivo . The levels of MKK3 and p-MKK3 ( A, B ) and P38 and p-P38 ( C, D ) in each group were detected by Western blot analysis with GAPDH as the internal reference. All experiments were repeated 3 times. The results are presented as mean ±SD. N=6. *** P<0.001 compared with the negative control group.
Article Snippet: The membranes were blocked with 5% skim milk or 1% bovine serum albumin, and then incubated with Rac1 antibody, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antibody (1: 1000; Proteintech, Wuhan, China), Cyclin D1 antibody (1: 1000; BOSTER, Wuhan, China), Cyclin E antibody, Cyclin B antibody (1: 500; Bioss, Beijing, China), metal matrix proteinase (MMP)-2 antibody, MMP-9 antibody, B cell lymphoma-2 (Bcl-2) antibody, Bcl-2-associated X protein (Bax) antibody, phosphorylated-MAP kinase (p-MKK3) antibody (1: 500; Sangon Biotech, Shanghai, China), caspase-3 antibody, caspase-9 antibody, poly ADP-ribose polymerase (PARP) antibody (1: 1000; Cell Signaling Technology, Beverly, MA, USA),
Techniques: Activation Assay, In Vivo, Western Blot, Negative Control